Leadership

MDIC’s Board of Directors consisting of world-class representatives from the medical technology industry, government, and patient groups who work together to advance the mission of the consortium.

Chip Hance

CEO / Regatta Medical

Andrew C. Fish

President and CEO / MDIC

Lucile Blaise

President, Sleep & Respiratory Care / ResMed

Andrew Cleeland

CEO / Fogarty Institute for Innovation

Rick Geoffrion

President and CEO / Cyrano Therapeutics, Inc.

Jijo James

Chief Medical Officer, Medical Devices | Johnson & Johnson / MDIC

Gary Johnson

Vice President, Regulatory Affairs, Clinical Research and Health Economics & Reimbursement / Abbott

Krishna Kandarpa

Director, Research Sciences and Strategic Directions / NIBIB, NIH

Esther Krofah

Executive Vice President / Milken Institute Health

Trang Ly

SVP and Chief Medical Officer / Insulet Corporation

Laura Mauri

SVP & Chief Scientific, Medical and Regulatory Officer / Medtronic

Jody Powell

Vice President, Global Regulatory Affairs and Quality Assurance / Stryker

Randall L. Rutta

CEO / National Health Council

Peter Saltonstall

President and CEO / National Organization for Rare Disorders (NORD)

Kevin Sayer

Chairman President & CEO | DEXCOM / MDIC

Ami E. Simunovich

EVP, Chief Quality & Regulatory Officer, and Public Affairs / BD

Kenneth Stein

Senior Vice President & Chief Medical Officer Cardiac Rhythm Management and Global Health Policy / Boston Scientific

Tamara Syrek Jensen

Director, Coverage and Analysis Group (CAG) / Centers for Medicare & Medicaid Services (CMS)

Nadim Yared

President and CEO / CVRx